MSAM
RKDA icon

Moloney Securities Asset Management’s Arcadia Biosciences RKDA Stock Holding History

Moloney Securities Asset Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,796
Closed -$198K – 451
2021
Q1 		$198K Buy
+1,796
New +$220K 0.04% 383

Other funds holding RKDA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moloney Securities Asset Management's RKDA Position: Q2 2021 in Review

Moloney Securities Asset Management sold out of Arcadia Biosciences (RKDA) in Q2 2021, closing a stake of 1,796 shares — an estimated $198K sold.

Moloney Securities Asset Management first reported a position in RKDA in Q1 2021 and held it in 1 quarter. The position peaked at $198K in Q1 2021. 27 funds tracked by Wall St. Rank hold RKDA as of Q2 2021.

  • Moloney Securities Asset Management reported no remaining Arcadia Biosciences position as of Q2 2021 after selling out during the quarter.
  • Moloney Securities Asset Management sold 1,796 Arcadia Biosciences shares in Q2 2021, an estimated $198K.
  • Moloney Securities Asset Management first reported a position in Arcadia Biosciences in Q1 2021 and held it in 1 quarter.
  • Moloney Securities Asset Management's Arcadia Biosciences position peaked at $198K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2021.

Based on Moloney Securities Asset Management's 13F filing for Q2 2021, filed 26 Jul 2021.